openPR Logo
Press release

Clinical Trial Management (CTM) Market Expected to face $1,371 Million by 2023

01-14-2019 02:30 PM CET | Health & Medicine

Press release from: Allied Market Research

Clinical Trial Management Market

Clinical Trial Management Market

According to a new report published by Allied Market Research, titled, "Clinical Trial Management Market by Delivery Mode, Product, Component, End Users, and Region: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global clinical trial management market accounted for $570 million in 2016, and is estimated to reach $1,371 million by 2023, registering a CAGR of 13.4% from 2017 to 2023. North America is the highest contributor in the clinical trial management market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period.

Clinical trial management system (CTMS) helps in the maintenance and management of the vast and highly complex data obtained from clinical trials. The system also tracks the clinical trial occurring in different parts of the word and the data can be analyzed routinely through multiple regression, simulation and other models. In addition, the use of clinical trial management systems helps optimize time management and enhance the connectivity and reduce the communication gap between the researchers and their investors.

Request for Sample Report at: https://www.alliedmarketresearch.com/request-sample/2575

The major driving factors for the market growth are surge in the trend of outsourcing of clinical trials and the rise in the number of clinical trials owing to the large demand for novel therapeutic drugs and medical devices. Moreover, the increase in prevalence of chronic diseases and increase in awareness regarding the benefits of using CTM can fuel the growth of the clinical trial management market. In addition, the rise in the expenditure and number of R&D activity by various pharmaceutical companies also help increase the demand for clinical trial management systems. However, high cost associated with CTM and lack of skilled professionals is projected to hamper the market growth.

Among the component, software is the dominant segment in the CTM market due to the availability of advanced software that make improve the efficiency and productivity of the researchers. Web-based has the largest share of the global CTMS market due to the advantages as enhances quality and productivity of clinical trials, better time management, and ease of access.

Enterprise-based system is the dominant segment contributing toward the market growth. However, site-based CTM systems are expected to be fastest growing segment as they are easier to use. Pharmaceutical and biopharmaceutical companies is dominant segment owing to the large number of clinical trials conducted by this segment for the development of novel therapeutic drugs and medical devices.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/2575

KEY FINDINGS OF THE STUDY

Site-based CTM is projected to grow at the highest rate during the analysis period.
North America dominated global clinical trial management market in 2016, and is projected to continue its dominance in future.
China is expected to grow highest in the Asia-Pacific region during the forecast period.
Clinical research organizations is the fastest growing segment among the end user in 2016.
Services segment is expected to be the fastest growing segment during the forecast period.
In 2016, North America was the dominant revenue-generating region, owing to the large number of clinical trials conducted in the region, presence of high disposable income, and high adoption of advanced technology. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, attributable to presence of populace countries such as India and China leading to availability of large patient population and rise in healthcare expenditure.

The key players operating in the global clinical trial management market include Oracle, Medidata Solutions, Parexel, BioClinica, Inc., Bio-Optronics, IBM, MedNet Solutions, Veeva Systems, Forte Research Systems, and Merge Healthcare Incorporated. Other prominent players in the value chain include Mednet Solutions, Arisglobal, eClinForce Inc., DZS Software Solutions, DSG, Inc., Guger Technologies Inc., ICON, Plc., ChemWare Inc., and iWeb Technologies Limited.

Ask for discount before buying: https://www.alliedmarketresearch.com/get-discount/2575

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Trial Management (CTM) Market Expected to face $1,371 Million by 2023 here

News-ID: 1495587 • Views:

More Releases from Allied Market Research

Polyisoprene Market Size 2024 by Region, Type and Application, Forecast 2031
Polyisoprene Market Size 2024 by Region, Type and Application, Forecast 2031
The global polyisoprene industry was estimated at $21.5 billion in 2021, and is anticipated to hit $36.4 billion by 2031, registering a CAGR of 5.52% from 2022 to 2031. Rise in demand for elastomers in the automotive, industrial, footwear, and medical industries drive the growth of the global polyisoprene market. Moreover, increase in usage of polyisoprene in surgical gloves has supplemented the growth yet more. Simultaneously, several growth prospects in the developing and developed economies have also been
Polyisoprene Market Size 2024 by Region, Type and Application, Forecast 2031
Polyisoprene Market Size 2024 by Region, Type and Application, Forecast 2031
The global polyisoprene industry was estimated at $21.5 billion in 2021, and is anticipated to hit $36.4 billion by 2031, registering a CAGR of 5.52% from 2022 to 2031. Rise in demand for elastomers in the automotive, industrial, footwear, and medical industries drive the growth of the global polyisoprene market. Moreover, increase in usage of polyisoprene in surgical gloves has supplemented the growth yet more. Simultaneously, several growth prospects in the developing and developed economies have also been
Polyisoprene Market Size 2024 by Region, Type and Application, Forecast 2031
Polyisoprene Market Size 2024 by Region, Type and Application, Forecast 2031
The global polyisoprene industry was estimated at $21.5 billion in 2021, and is anticipated to hit $36.4 billion by 2031, registering a CAGR of 5.52% from 2022 to 2031. Rise in demand for elastomers in the automotive, industrial, footwear, and medical industries drive the growth of the global polyisoprene market. Moreover, increase in usage of polyisoprene in surgical gloves has supplemented the growth yet more. Simultaneously, several growth prospects in the developing and developed economies have also been
Polyisoprene Market Size 2024 by Region, Type and Application, Forecast 2031
Polyisoprene Market Size 2024 by Region, Type and Application, Forecast 2031
The global polyisoprene industry was estimated at $21.5 billion in 2021, and is anticipated to hit $36.4 billion by 2031, registering a CAGR of 5.52% from 2022 to 2031. Rise in demand for elastomers in the automotive, industrial, footwear, and medical industries drive the growth of the global polyisoprene market. Moreover, increase in usage of polyisoprene in surgical gloves has supplemented the growth yet more. Simultaneously, several growth prospects in the developing and developed economies have also been

All 5 Releases


More Releases for Clinical

Clinical Laboratory Market in Indonesia, Clinical Laboratory Industry in Indones …
"Increase in healthcare expenditure from the Indonesian government has driven the growth of clinical laboratory market in Indonesia." Increase in Healthcare Awareness: Largely driven by increase in healthcare spending by aging population (~$ 260 per person by 2050), rising income levels, rising awareness for preventive testing, advanced healthcare diagnostic tests offerings, and central government's healthcare measures. Developments in Testing and Preference for Evidence based testing: There is also a rising number
Clinical solutions
Are you spending more time with yellow files than with patients? Healthbridge can change that with our intuitive and easy to use clinical platform that is designed specifically for the medical practitioner at the practice. smaller2 Easily access patient information Cloud-based technology enables you to store rich clinical information that can be easily accessed as and when you need it. Medical billing software innovation Become a paperless practice Create scripts, sick notes, and clinical notes electronically. Plus, have
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
Paediatric Clinical Trial Conference - When designing a Paediatric clinical tria …
Press Release – 12.02.2018 When designing a Paediatric clinical trial, a paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children. All applications for marketing authorisation for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral
Clinical Communication
According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions.
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry. The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical